BBIO:NASDAQ
BridgeBio Pharma Inc
$68.30
arrow_downward
-0.13%(-0.090) 1D
$68.50
arrow_upward
+0.29% (+0.20)bedtimeAfter hours
Closed: Sep 16, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBIO...
Open
$68.52
High
$69.46
Low
$67.10
Mkt. cap
13.35B
Avg. vol.
2.11M
Volume
4.79M
52-wk high
$93.42
52-wk low
$48.78
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
Open
$68.52
High
$69.46
Low
$67.10
Mkt. cap
13.35B
Avg. vol.
2.11M
Volume
4.79M
52-wk high
$93.42
52-wk low
$48.78
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
News stories
From web sources and news partners
Zacks
·
8 hours ago
BioMarin Stops Voxzogo Development for Noonan Syndrome
TradingView
·
1 day ago
BBIO: Attruby's clinical edge and new launches drive growth, targeting profitability by 2027
Investing.com
·
1 day ago
BridgeBio Pharma at Morgan Stanley conference: attruby drives growth
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1K
Founded2015
HeadquartersPalo Alto, California, United States
SectorBiotechnology
Websitebridgebio.com